ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Fresno, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Vijay Balasubramanian, MD
Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Vijay Balasubramanian, MD
Clinical Professor of Medicine, UCSF Medical Director of Pulmonary Hypertension-Community Regional Medical Center Vijay Balasubramanian, M.D., specializes in pulmonary disease. He is board certified in Internal Medicine. His residency and fellowship training were completed at the Medical College of Wisconsin.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- United Therapeutics
- ID
- NCT03045029
- Study Type
- Observational [Patient Registry]
- Participants
- Expecting 300 study participants
- Last Updated